BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7443238)

  • 1. Treatment of malignant tumors of the nasopharynx.
    Wang CC
    Otolaryngol Clin North Am; 1980; 13(3):477-81. PubMed ID: 7443238
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radiotherapy of recurrent nasopharyngeal carcinoma--analysis of 104 cases].
    Chen XY
    Zhonghua Zhong Liu Za Zhi; 1984 Mar; 6(2):134-7. PubMed ID: 6468256
    [No Abstract]   [Full Text] [Related]  

  • 3. [Statistical data on results of radiotherapy and survival of patients with cancer of the nasopharynx].
    Bykov VL
    Vestn Otorinolaringol; 1988; (4):61-3. PubMed ID: 3188331
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic factors for loco-regional control and outcome of re-irradiation for patients with poorly-differentiated squamous cell carcinoma of the nasopharynx.
    Mitsuhashi N; Sakurai H; Takahashi M; Maebayashi K; Tamaki Y; Hashida I; Akimoto T; Nakamoto S; Takahashi T; Hayakawa K
    Jpn J Clin Oncol; 1995 Jun; 25(3):72-8. PubMed ID: 7596051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ORL brachytherapy. Salvage brachytherapy in ORL cancers (oral cavity, oropharynx, nasopharynx)].
    Ardiet JM; Coquard R; Peiffert D; Montbarbon X; Pernot M; Gérard JP
    Bull Cancer Radiother; 1995; 82(2):199-202. PubMed ID: 7546891
    [No Abstract]   [Full Text] [Related]  

  • 6. Contribution of the hyperdynamic radiotherapy in the treatment of the nasopharynx tumors.
    Karageorgis P; Emmanuil E; Throuvalas N
    Strahlentherapie; 1982 Mar; 158(3):156-9. PubMed ID: 7071878
    [No Abstract]   [Full Text] [Related]  

  • 7. [Malignant tumors in otorhinolaryngology. I. Tumors of the epipharynx].
    Kup W; Lange D
    Arch Geschwulstforsch; 1969; 34(1):62-86. PubMed ID: 4920866
    [No Abstract]   [Full Text] [Related]  

  • 8. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
    Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
    Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of interstitial brachytherapy via parapharynx involvement transnasal approach to enhance dose in radiotherapy for nasopharyngeal carcinoma].
    Chen MY; Cao XP; Sun R; Hua YJ; Li AJ; Liu YY; Ouyang Y; Guo L; Chen QY; Hong MH
    Ai Zheng; 2007 May; 26(5):513-8. PubMed ID: 17672943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Irradiation field design according to locoregional relapse sites after radiotherapy of nasopharyngeal carcinoma].
    Luo W; Tang YQ; Huang Y; Lu LX; Lu TX
    Ai Zheng; 2006 Feb; 25(2):209-11. PubMed ID: 16480588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reirradiation of locally recurrent nasopharyngeal carcinoma.
    Lengyel E; Baricza K; Somogyi A; Olajos J; Pápai Z; Godény M; Németh G; Esik O
    Strahlenther Onkol; 2003 May; 179(5):298-305. PubMed ID: 12740656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment results in patients with juvenile angiofibroma of the nasopharynx].
    Lantsov AA; Kovaleva LM; Ushakov VS; Mefodovskiĭ AA
    Vestn Otorinolaringol; 1998; (4):12-4. PubMed ID: 9752088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma of the nasopharynx an optimization of radiotherapeutic management for tumor control and spinal cord injury.
    Tokars RP; Griem ML
    Int J Radiat Oncol Biol Phys; 1979 Oct; 5(10):1741-8. PubMed ID: 528237
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic factors and outcome for nasopharyngeal carcinoma.
    Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intensity modulated radiation therapy for 49 patients with recurrent nasopharyngeal carcinoma].
    Lu TX; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Zeng ZF; Huang SM; Lin CG; Cui NJ
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):386-9. PubMed ID: 12921573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma.
    Yau TK; Sze WM; Lee WM; Yeung MW; Leung KC; Hung WM; Chan WI
    Head Neck; 2004 Dec; 26(12):1024-30. PubMed ID: 15390194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of the poststyloid space in the treatment of nasopharyngeal carcinoma.
    De Renzis C; Gaeta M; Pandolfo I; Blandino G
    Rays; 1987; 12(3):95-9. PubMed ID: 3503331
    [No Abstract]   [Full Text] [Related]  

  • 20. Malignant tumors of the nasopharynx.
    Chen KY; Fletcher GH
    Radiology; 1971 Apr; 99(1):165-71. PubMed ID: 5548672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.